Overcoming the blood—brain barrier: FDA-approved drug could aid therapeutic delivery
Researchers from Cornell University (NY, USA) have demonstrated that an existing FDA-approved drug could be utilized to deliver therapeutic agents to the brain, potentially facilitating treatment of Alzheimer’s disease and chemotherapy-resistant cancers.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet – the medicinal chemistry network
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.